![](https://i0.wp.com/glhf.org/wp-content/uploads/2019/07/Highly-Detailed-DNA-Re-Sized.jpg?resize=668%2C335&ssl=1)
uniQure Announces End of Clinical Hold on Hemophilia B Gene Therapy Program
Late last year the FDA put a clinical hold on the program in response to a single trial participant who was diagnosed with a common form of liver cancer.
Source: National Hemophilia Foundation